Verve Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell VERV and other ETFs, options, and stocks.

About VERV

Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines. 

CEO
Sekar Kathiresan
CEOSekar Kathiresan
Employees
113
Employees113
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2018
Founded2018
Employees
113
Employees113

VERV Key Statistics

Market cap
2.10B
Market cap2.10B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
1.65M
Average volume1.65M
High today
$36.38
High today$36.38
Low today
$34.13
Low today$34.13
Open price
$35.00
Open price$35.00
Volume
1.68M
Volume1.68M
52 Week high
$56.18
52 Week high$56.18
52 Week low
$10.70
52 Week low$10.70

Analyst ratings

88%

of 8 ratings
Buy
87.5%
Hold
12.5%
Sell
0%

VERV Earnings

-$2.13
-$1.42
-$0.71
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 10, Pre-Market
ActualExpected Nov 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.